Schedule 13G ownership disclosure

BioAge Labs Inc

Common Stock, par value $0.00001 per share · CUSIP: 09077V100

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ADAR1 Capital Management, LLC

    Shares: 1,937,123.00 · Class: 5.4%

  • Daniel Schneeberger

    Shares: 1,937,123.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-078851
Form type
SCHEDULE 13G
Filer
ADAR1 Capital Management, LLC
CIK
CIK 1940272
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub